Serial #79411250
LIVE

Serial Number

79411250

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79411250 Trademark

Serial Number: 79411250 • Registration: 7910433

Serial #79411250 is a trademark filed by NOVARTIS AG on September 10, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 10, 2024

Registration Date

August 26, 2025

Published for Opposition

July 8, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 21, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 2, 2026 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Mar 15, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 15, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2025 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 16, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 16, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 16, 2025 COAR
REFUSAL PROCESSED BY IB
May 4, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2024 REPR